People

John D. Carroll is a partner in the Antitrust practice in the Washington, D.C., office of King & Spalding.  His practice focuses on civil and criminal antitrust matters, including mergers & acquisitions, strategic counseling and compliance, and global cartel investigations, where he represents clients before the Department of Justice Antitrust Division, Federal Trade Commission, and international and state antitrust enforcement authorities.

John has been recognized by Legal 500 and Global Competition Review, and was named a “Rising Star” by Washington Super Lawyers.  He frequently speaks and writes on antitrust issues and has held leadership positions in the American Bar Association Section of Antitrust Law (currently Vice-Chair, Healthcare & Pharmaceuticals Committee) and the American Health Lawyers Association Antitrust Practice Group (former Social Media Chair).

John joined King & Spalding from Ropes & Gray.  Prior to joining Ropes & Gray, he was in the Mergers I Division of the Federal Trade Commission’s Bureau of Competition for several years.  While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the technology, consumer products, defense, healthcare, and pharmaceutical industries and received an Award for Meritorious Service for work on merger litigation.

Recent Speaking Engagements

  • Moderator, “Recent Developments in Health Care & Pharmaceuticals," American Bar Association, Section of Antitrust Law, May 18, 2020  
  • Panelist, "Federal Antitrust Enforcement of the FinTech Industry," Electronic Transactions Association, April 10, 2019
  • Panelist, "Healthcare Antitrust Educational Call," American Health Lawyers Association, December 11, 2018
  • Panelist, "Exclusionary Practices: An Overview," American Health Lawyers Association Annual Meeting, June 27, 2018
  • Panelist, "Recent Developments in Healthcare & Pharmaceuticals," American Bar Association, Antitrust Section, January 24, 2018
  • Panelist, "300 Days and Counting, Antitrust in the Trump Administration, What We've Seen and What to Expect," King & Spalding Pharma U, November 1, 2017

Recent Publications

  • Editor, The Healthcare Antitrust Handbook (forthcoming) ABA Publications
  • Author, "Antitrust & Covid-19 in the U.S.: Four Key Issues for Healthcare Providers,"
     Competition Policy International, May 14, 2020
  • Co-Editor, Antitrust Law Developments, 2020 Update, ABA Publications 
  • Contributing Editor, Pharmaceutical Industry Handbook (2018), ABA Publications
  • Supervising Editor, The Energy Industry Handbook (2017) ABA Publications
Full Bio

Credentials

J.D., George Washington University

B.A., University of Michigan

District of Columbia

Maryland

Supreme Court of the United States

Recognized as leading antitrust lawyer


Legal 500

Named an antitrust “Rising Star”


Washington SuperLawyers

Icon close

Close

Recognition

Recognized as leading antitrust lawyer


Legal 500

Named an antitrust “Rising Star”


Washington SuperLawyers

Matters

Healthcare & Life Sciences

Represented St. Luke’s University Health Network on antitrust aspects of in its entry into Civica Rx, a not-for-profit generic drug company, as a founding member

Represented St. Luke's University Health Network on antitrust aspects of its acquisition of Easton Hospital

Represented Ohio State University Wexner Medical Center and Mercy Health on antitrust aspects of the formation of a statewide affiliation to address Ohio’s critical health needs

See more
Icon close

Close

Matters

Healthcare & Life Sciences

Represented St. Luke’s University Health Network on antitrust aspects of in its entry into Civica Rx, a not-for-profit generic drug company, as a founding member

Represented St. Luke's University Health Network on antitrust aspects of its acquisition of Easton Hospital

Represented Ohio State University Wexner Medical Center and Mercy Health on antitrust aspects of the formation of a statewide affiliation to address Ohio’s critical health needs

Represented Atrium Health on antitrust aspects of the formation of its Musculoskeletal Institute and entry into a co-management arrangement with physician groups

Represented Ochsner Health System it its formation of JOA with Slidell Memorial Hospital

Represented Owens and Minor on antitrust aspects of it acquisition of Byram Healthcare from Mediq

Currently advising health systems and physician groups on variety of antitrust issues, including network formation and potential transactions

Currently advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures

Consumer Products & Entertainment

Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands

Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain

Representation of Hanesbrands Inc. in antitrust aspects of its acquisition of Maidenform Brands, Inc., a leading consumer goods company.

Represented Bass Pro Group in its successful defense of an FTC investigation of its acquisition of Fishing Holdings LLC, a manufacturer of fishing boats that include Ranger Boats and the Stratos and Triton boat brands.

Manufacturing

Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper & Packaging

Represented Forterra Building Products, a portfolio company of LoneStar Funds, in the formation of a joint venture with a competitor

Technology & FinTech

Represented Total System Services on antitrust aspects of its $54 billion merger of equals with Global Payments

Currently advising leading technology companies on range of antitrust issues regarding investigations and transactions

Global Cartel Investigations

Defended multinational companies in criminal investigations alleging antitrust conspiracies

Represented an executive of international auto parts company in connection with a cartel investigation in that industry.

Insights

Article · Source: CPI Antitrust Chronicle

May 14, 2020
Antitrust & COVID-19 in the U.S.: Four Key Issues for Healthcare Providers

Article · Source: Competition Policy International

May 14, 2020
Antitrust & Covid-19 in the U.S.: Four Key Issues for Healthcare Providers

View all

Matters

Healthcare & Life Sciences

Represented St. Luke’s University Health Network on antitrust aspects of in its entry into Civica Rx, a not-for-profit generic drug company, as a founding member

Represented St. Luke's University Health Network on antitrust aspects of its acquisition of Easton Hospital

Represented Ohio State University Wexner Medical Center and Mercy Health on antitrust aspects of the formation of a statewide affiliation to address Ohio’s critical health needs

See more
Icon close

Close

Matters

Healthcare & Life Sciences

Represented St. Luke’s University Health Network on antitrust aspects of in its entry into Civica Rx, a not-for-profit generic drug company, as a founding member

Represented St. Luke's University Health Network on antitrust aspects of its acquisition of Easton Hospital

Represented Ohio State University Wexner Medical Center and Mercy Health on antitrust aspects of the formation of a statewide affiliation to address Ohio’s critical health needs

Represented Atrium Health on antitrust aspects of the formation of its Musculoskeletal Institute and entry into a co-management arrangement with physician groups

Represented Ochsner Health System it its formation of JOA with Slidell Memorial Hospital

Represented Owens and Minor on antitrust aspects of it acquisition of Byram Healthcare from Mediq

Currently advising health systems and physician groups on variety of antitrust issues, including network formation and potential transactions

Currently advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures

Consumer Products & Entertainment

Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands

Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain

Representation of Hanesbrands Inc. in antitrust aspects of its acquisition of Maidenform Brands, Inc., a leading consumer goods company.

Represented Bass Pro Group in its successful defense of an FTC investigation of its acquisition of Fishing Holdings LLC, a manufacturer of fishing boats that include Ranger Boats and the Stratos and Triton boat brands.

Manufacturing

Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper & Packaging

Represented Forterra Building Products, a portfolio company of LoneStar Funds, in the formation of a joint venture with a competitor

Technology & FinTech

Represented Total System Services on antitrust aspects of its $54 billion merger of equals with Global Payments

Currently advising leading technology companies on range of antitrust issues regarding investigations and transactions

Global Cartel Investigations

Defended multinational companies in criminal investigations alleging antitrust conspiracies

Represented an executive of international auto parts company in connection with a cartel investigation in that industry.

Insights

Article · Source: CPI Antitrust Chronicle

May 14, 2020
Antitrust & COVID-19 in the U.S.: Four Key Issues for Healthcare Providers

Article · Source: Competition Policy International

May 14, 2020
Antitrust & Covid-19 in the U.S.: Four Key Issues for Healthcare Providers

View all

Credentials

J.D., George Washington University

B.A., University of Michigan

District of Columbia

Maryland

Supreme Court of the United States

Recognized as leading antitrust lawyer


Legal 500

Named an antitrust “Rising Star”


Washington SuperLawyers

Icon close

Close

Recognition

Recognized as leading antitrust lawyer


Legal 500

Named an antitrust “Rising Star”


Washington SuperLawyers